Fundz

Watching West Pharmaceutical Services, Inc.? See every signal: funding, hires, M&A, contracts, sentiment.

Book a demoChoose your plan
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →
Back to SEC Filings
Acquisition/DispositionItem 2.01 · 8-KLOW RiskNeutral

West Pharmaceutical Services, Inc.

westpharma.com
Filed: Jul 23, 2026Exton, PennsylvaniaCIK: 0000105770Health Care
Full company profileView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

West Pharmaceutical Services announced Q2 2026 financial results on July 23, 2026, providing investors with updated operational performance metrics and market position insights.

Key Takeaways

Company released second-quarter 2026 financial results including quarterly revenue and earnings figures

Press release and presentation materials were made available to investors and stakeholders

1 more takeaway

Related Filings (1)

1 more filing from West Pharmaceutical Services, Inc. in the last 90 days

Filing Overview

Form Type8-K
Filing DateJul 23, 2026
Item2.01
CategoryAcquisition/Disposition
CIK0000105770
Accession #wst-20260723
Risk LevelLOW
SentimentNeutral
Signalinformational
Topics
earnings

What This Means

The company completed a major acquisition or sold off a significant asset. This reshapes the company's portfolio and strategic direction.
View Full Filing on SEC.govBrowse More Filings

West Pharmaceutical Services, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.